6 result(s) displayed (1 - 6 of 6):

Will Senators spark FTC review of CVS Caremark? (from Corporate Dealmaker)

When CVS Corp. combined with pharmacy benefits manager Caremark Rx Inc. for $26 billion, creating CVS Caremark Corp. (NYSE:CVS) in 2007, some heads turned at the drugstore's aggressive move into PBM, where it faces possible conflicts of interest.Lately, objections to CVS' dual role as both a major seller of medicines...

Posted on July 31, 2009 2:01 PM

Deal approvals: Glaxo, Oracle, Pfizer (from Corporate Dealmaker)

In the long winding road from "secret merger talks" to deal completion, bankers, lawyers and corporate dealmakers alike breathe easier when their hard work is met with regulatory and shareholder approvals along the way. Collecting fees is also a source of comfort. Sure, they get money from retainer and reimbursement...

Posted on July 17, 2009 3:01 PM

CVS-Caremark merger called into question (from Corporate Dealmaker)

The Federal Trade Commission was asked to re-evaluate a 2007 deal where CVS bought Caremark Rx Inc. for $26 billion to create CVS Caremark Corp. (NYSE:CVS). The National Community Pharmacists Association, with about 23,000 member pharmacies, says: "Community pharmacists have received many complaints from patients and pharmacists about CVS Caremark's...

Posted on May 14, 2009 9:01 AM

Apple, Google face FTC antitrust probe (from Corporate Dealmaker)

Google Inc. (NASDAQ:GOOG) CEO Eric Schmidt and former Genentech Inc. chief executive Arthur Levinson sit on the boards of both Google and Apple Inc. (NASDAQ:AAPL). According to The New York Times, that isn't sitting well with the Federal Trade Commission, who thinks it violates the Clayton Antitrust Act of 1914,...

Posted on May 5, 2009 9:04 AM

The Boston Sci-Guidant deal revisited (from Corporate Dealmaker)

Viewed from a patent perspective, the acquisition makes a little more sense -- for both offensive and defensive reasons.

Posted on December 15, 2006 10:02 PM

Patent reform gets going in Washington (from Corporate Dealmaker)

Kodak's Jeff Hawley, current president of the Intellectual Proprty Owners Association, discusses what's in store.

Posted on June 15, 2005 4:58 PM